capecitabine has been researched along with Cardiovascular Stroke in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 6 (85.71) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Godwin, SA; Kosmas, C; Koulouris, E; Kyratlidis, K; Lampropoulos, S; Pavlidis, K; Roditis, P; Tzimou, M; Zafiris, A | 1 |
Larsen, FO; Nielsen, DL; Polk, A; Schou, M; Shahmarvand, N; Vaage-Nilsen, M; Vistisen, K | 1 |
Kok, WE; Koopman, M; Kwakman, JJ; Mol, L; Punt, CJ; Simkens, LH | 1 |
Curzen, NP; Ferchow, L; Hobson, A; Scott, PA | 1 |
Celiker, E; Eren, M; Güvenç, TS; Ilhan, E; Ozcan, KS | 1 |
Allum, WH; Blazeby, JM; Coxon, F; Cunningham, D; Evans, L; Falk, S; Ford, D; Griffin, M; Hall, M; Iveson, TJ; Langley, RE; Middleton, GW; Okines, AF; Petty, RD; Plummer, C; Seymour, M; Slater, S; Smith, D; Stenning, SP; Stevenson, L; Thompson, LC; Waters, J | 1 |
Kodama, M; Mekata, E; Okumura, K; Shiogai, Y; Tani, S; Tani, T | 1 |
1 review(s) available for capecitabine and Cardiovascular Stroke
Article | Year |
---|---|
Report of two cases of acute cardiac adverse events in patients with colorectal carcinoma receiving oral capecitabine.
Topics: Acute Disease; Aged; Antimetabolites, Antineoplastic; Capecitabine; Colorectal Neoplasms; Humans; Male; Middle Aged; Myocardial Infarction | 2017 |
1 trial(s) available for capecitabine and Cardiovascular Stroke
Article | Year |
---|---|
Bevacizumab with peri-operative epirubicin, cisplatin and capecitabine (ECX) in localised gastro-oesophageal adenocarcinoma: a safety report.
Topics: Adenocarcinoma; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capecitabine; Cisplatin; Deoxycytidine; Epirubicin; Esophageal Neoplasms; Female; Fluorouracil; Humans; Male; Middle Aged; Myocardial Infarction; Stomach Neoplasms; Stroke Volume; Thromboembolism; Treatment Outcome | 2013 |
5 other study(ies) available for capecitabine and Cardiovascular Stroke
Article | Year |
---|---|
Incidence and risk factors for capecitabine-induced symptomatic cardiotoxicity: a retrospective study of 452 consecutive patients with metastatic breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Arrhythmias, Cardiac; Breast Neoplasms; Capecitabine; Cardiotoxicity; Chest Pain; Comorbidity; Denmark; Female; Humans; Incidence; Middle Aged; Myocardial Infarction; Neoplasm Metastasis; Retrospective Studies; Risk Factors | 2016 |
Incidence of capecitabine-related cardiotoxicity in different treatment schedules of metastatic colorectal cancer: A retrospective analysis of the CAIRO studies of the Dutch Colorectal Cancer Group.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Arrhythmias, Cardiac; Bevacizumab; Capecitabine; Carcinoma; Cardiotoxicity; Chest Pain; Colorectal Neoplasms; Heart Failure; Humans; Incidence; Myocardial Infarction; Myocardial Ischemia; Neoplasm Metastasis; Netherlands; Organoplatinum Compounds; Oxaliplatin; Randomized Controlled Trials as Topic; Retrospective Studies | 2017 |
Coronary spasm induced by capecitabine mimicks ST elevation myocardial infarction.
Topics: Aged; Antimetabolites, Antineoplastic; Capecitabine; Chest Pain; Colorectal Neoplasms; Coronary Vasospasm; Deoxycytidine; Diagnosis, Differential; Electrocardiography; Fluorouracil; Humans; Male; Middle Aged; Myocardial Infarction; Risk Factors; Treatment Outcome | 2008 |
Acute myocardial infarction after capecitabine treatment: not always vasospasm is responsible.
Topics: Capecitabine; Coronary Thrombosis; Coronary Vasospasm; Deoxycytidine; Female; Fluorouracil; Humans; Middle Aged; Myocardial Infarction | 2012 |
[A case of advanced rectal cancer with bladder carcinoma salvaged from myocardial infarction during operation, showing tumor regression by XELOX treatment, good quality of life].
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Deoxycytidine; Fluorouracil; Humans; Intraoperative Complications; Male; Myocardial Infarction; Neoplasms, Multiple Primary; Oxaloacetates; Quality of Life; Rectal Neoplasms; Salvage Therapy; Urinary Bladder Neoplasms | 2013 |